---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-064675"
form_type: "8-K"
ticker: "NRXP"
cik: "0001719406"
company_name: "NRX Pharmaceuticals, Inc."
filed_at: "2024-05-23T23:59:59+00:00"
generated_at: "2026-06-01T09:15:34.971768+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# NRx Pharmaceuticals underwriters exercise overallotment, purchase 91,050 shares at $3.30

## Summary
- Underwriters exercised option to buy 91,050 additional shares at $3.30 per share from previously announced offering.
- Gross proceeds from overallotment approximately $300,465; closed May 23, 2024.
- Overallotment exercise completed; shares issued at same price as initial public offering.

## SEC filing metadata
- accession: 0001104659-24-064675
- form_type: 8-K
- ticker: NRXP
- cik: 0001719406
- company_name: NRX Pharmaceuticals, Inc.
- filed_at: 2024-05-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1719406/000110465924064675/0001104659-24-064675-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1719406/000110465924064675/tm2415394d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-064675
- JSON: https://secwatch.observer/filing/0001104659-24-064675.json
- Plain text: https://secwatch.observer/filing/0001104659-24-064675.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.